Undifferentiated Ovarian Carcinoma Completed Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028876 (Undifferentiated Ovarian Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00814086Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerTreatment